Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. From Wikipedia
By gaining a primary US listing, the company seeks to tap deeper capital pools and secure a path into leading American stock indices pending shareholder approval.